Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE. This decade of success has resulted in explosive investment into the development of […]

Rapid development and rising demand of oligonucleotide drugs is fuelling revolutionary steps in biopharma investment and technology advancement for pipeline progression. The prospect of defining impurities and suitable CQAs for […]

The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire […]